On the recordApril 28, 2010
So, in your view, there's absolutely no justification for treating this program differently from the other TARP program and excluding your office from conducting vigorous oversight of the program.
Source
congress.govEditor's note · Context
Collins emphasizes the need for consistent oversight across programs.
Share & report
More from Susan Collins
Jun 10, 2025
As the senator representing … the oldest state in the nation, this is a particular concern.
Jun 10, 2025
It is leading to scientists leaving the United States for opportunities in other countries. It’s causing clinical trials to be halted and promising medical research to be abandoned.
Other voices in this conversation
